18 Mar 2009   |   News

ReNeuron raises £3M for neural foetal stem cell trial


Stem cell specialist ReNeuron Group plc is aiming to raise up to £3 million via a placing of up to 100 million new shares, providing the hard-up company with sufficient working capital for at least the next 12 months.

The money will fund the Phase I trial of ReN001, ReNeuron’s foetal neural stem cell product, in the treatment of stroke. The trial was approved by UK regulators in January.

Never miss an update from Science|Business:   Newsletter sign-up